No Picture
News

CureVac walks away from Arcturus’ urea cycle disorder drug, but partnership remains intact

Arcturus Therapeutics had a melodramatic 2018 — the San Diego biotech’s CEO Joseph Payne was asked to leave for putting his interests before the RNA company, but he fought back with the support of shareholders, ousted the board that spearheaded his ous… […]